Rocket Pharma gets FDA nod for first pediatric gene therapy targeting severe LAD-I
The approval covers pediatric patients without a matched sibling donor for stem cell transplant
The approval covers pediatric patients without a matched sibling donor for stem cell transplant
Paroxetine extended-release tablets are indicated for the treatment of major depressive disorder
As Tracky launches integrated health solution
The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities
The radiotherapy systems include TrueBeam, TrueBeam STx, VitalBeam, and Edge
The once-weekly treatment targets Type 2 Diabetes Mellitus (T2DM) with demonstrated efficacy and safety
India’s largest glycolic acid manufacturer will unveil AviGa Bio HP70 on April 14, 2026
Subscribe To Our Newsletter & Stay Updated